Hints and tips:
...The Medicines and Healthcare products Regulatory Agency, the UK drugs watchdog, is assessing whether conditional marketing authorisation should be renewed for Merck’s molnupiravir, also known by the trade...
...Olczak admitted that a separate target to derive $1bn of annual revenues from healthcare and wellness products by 2025 was “questionable” due to clients of Vectura, which PMI bought in 2021, shunning the...
...Olczak said he would “very likely” request a buyback clause if Philip Morris does sell its Russian assets, providing a chance to return if the war ends....
...It is “possible” that the oral Covid drug molnupiravir will not receive approval at all, one of the people said. The EMA declined to comment on its ongoing review....
...Its key target in moving “beyond nicotine”, to generate $1bn in revenues from its wellness and healthcare division by 2025, is “questionable”, he admitted. Vectura’s figures aren’t disclosed....
...The former Philip Morris rebranded as Altria in 2003 and spun out its international operations as PMI in 2008....
...Swedish Match produces snus, a popular tobacco product in Scandinavia, as well as oral nicotine pouches, the fastest-growing alternative nicotine category....
...Albert Bourla, Pfizer chief executive, said on Monday that a local contract manufacturer was gearing up to begin production as demand skyrockets for the oral antiviral treatment amid a supply crunch in China...
...Eli Lilly, Amgen, Pfizer and Regeneron are among the companies aiming to compete with market leader Novo Nordisk in a category which analysts say is rapidly becoming a healthcare priority and could produce...
...Les Funtleyder, a healthcare portfolio manager at E Squared Capital Management, said he expected Pfizer would make a series of acquisitions this year....
...Philip Morris International has struck a $16bn deal to buy Swedish Match, as the tobacco company makes its biggest bet yet on alternatives to cigarettes....
...This was far higher than its only rival, oral antiviral Merck’s Lagevrio, which cut the risk by about 30 per cent....
...Philip Morris International is nearing a deal to acquire European rival Swedish Match for about $16bn including debt, as the tobacco group bets on the rapidly growing market for cigarette alternatives....
...“It may come as a surprise to many of you,” he wrote, “that PMI is evolving into a broader healthcare and wellness company.” PMI is Marlboro cigarette-maker Philip Morris International....
...stock markets are dominated by “old economy” sectors such as commodities and financials, and — just as in Europe but unlike in the US — there are far fewer specialist funds in sectors such as tech and healthcare...
...Such interactions were “alarmingly overlooked in the setting of the Covid-19 healthcare crisis”, the authors of the study concluded....
...Tobacco groups have a horrible history, but the healthcare industry is hardly squeaky clean....
...PMI, which makes Marlboro cigarettes, outbid the US private equity firm Carlyle for control of Vectura, prompting complaints from healthcare charities that said Big Tobacco was an unsuitable owner of a healthcare...
...Frans van Houten, chief executive of Philips, has downplayed the litigation risks....
...The oral antivirals will be an important tool for ailing healthcare systems eager to reduce the burden of a potential influx of Covid-19 patients this winter....
...As an oral drug, the antiviral could be prescribed as an at-home treatment to cut the severity of the disease and reduce the impact of the pandemic on healthcare systems....
...It marks the first green light for molnupiravir, an easy-to-administer oral treatment that halved the risk of hospitalisation or death for people with mild to moderate Covid during clinical trials....
...plan to become a “healthcare and wellness company”....
...The private equity group has been stepping up its own attempts to buy European healthcare companies....
...There is a paradox in a tobacco giant moving into healthcare. Pharmaceuticals keep people alive. Cigarettes kill them....
International Edition